COc1ccc(-c2c(C#N)c(SCC(=O)Nc3ccc(C)c(C)c3)nc(C)c2C(=O)Nc2ccc(Cl)cc2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?